Shandong cord blood bank is the only formal and legal cord blood storage institution in Shandong Province approved by the National Health Commission, which undertakes the collection, preservation, preparation, scientific research and clinical export of cord blood stem cells in Shandong Province. It has been 29 years since 1993 was established. In the past twenty-nine years, I have never forgotten your initiative to make great efforts to explore the medical value of umbilical cord blood, and strive for the first line of umbilical cord blood medicine with youth and blood, bringing the fire of life to many patients and guarding life resources for many families.
The umbilical cord blood bank adheres to the two-wheel drive of inheritance and innovation, constantly promotes the development of umbilical cord blood research and helps more clinical transformation of umbilical cord blood technology. Relying on Qilu Hospital of Shandong University as technical support, an expert committee was set up to build and improve the echelon of blood bank talents, review the annual scientific research development plan and the direction of clinical application topics, enhance technical strength and technical reserves, and maintain a leading position in the professional field. After 29 years' accumulation, at present, the professional technicians in the cord blood bank have covered clinical medicine, medical examination, biology and other professional fields, and formed professional teams in hematology, genetics, low-temperature biomedicine, genetic testing and other disciplines, which passed on the technological development advantages of the blood bank from generation to generation, ensuring the rapid development of cord blood research and the scientific management of stem cell storage.
In addition, the cord blood bank actively carries out innovative exploration, deeply excavates the medical value of cord blood, and continuously expands its scientific and technological strength. Up to now, Shandong cord blood bank has established nearly 120 scientific research projects with more than 90 medical units inside and outside the province, involving solid tumors, hematological tumors, nervous system, reproductive system, sports medicine, cardiovascular system, liver disease, digestive system, endocrine system, neonatology and other fields. The treatment of autism, cerebral palsy, pulmonary dysplasia, ITP, SAA, AML and MDS in the elderly was deeply discussed and exchanged, and positive progress was made. In addition, three batches of umbilical cord blood mononuclear cells and mesenchymal stem cells have been certified by the US Food and Drug Administration in China, leading the industry.
Legal basis:
Measures for the administration of cord blood hematopoietic stem cell bank (for Trial Implementation)
Article 8 To apply for the establishment of a cord blood hematopoietic stem cell bank, it shall meet the requirements of the national planning and layout, and meet the following conditions in addition to the basic conditions for the establishment of a general blood bank:
(1) Having the foundation of hematology research and the ability of hematopoietic stem cell research;
(2) A design scheme with high cleanliness space and refrigeration equipment that can store not less than 65,438+00,000 copies of umbilical cord blood;
(3) Having laboratories and data storage rooms that meet GMP and GLP standards, such as hematology biology, HLA matching, detection of related pathogens, genetics and cryobiology, and cord blood treatment;
(4) Having instruments and equipment such as flow cytometry, program-controlled freezer, PCR, cell freezing, relevant detection and computer network management;
(5) Having technical, managerial and service personnel who independently carry out laboratory hematology, immunology, hematopoietic cell culture, detection, HLA matching, pathogen detection, cryobiology, management, quality control and monitoring, instrument operation, data storage and enjoyment;
(6) Having a safe and reliable source of umbilical cord blood;
(seven) have the ability to raise construction funds and operating funds through multiple channels.